MBHB Attorneys Aaron Gin and Bryan Helwig Co-Author Article Entitled, “FDA Signals Fast-Track Approval for AI-Based Medical Devices”

McDonnell Boehnen Hulbert & Berghoff LLP attorneys Aaron Gin, Ph.D. and Bryan Helwig, Ph.D., co-authored a May 10, 2018 Bloomberg Law article entitled, “FDA Signals Fast-Track Approval for AI-Based Medical Devices.” The Food and Drug Administration has signaled a transition in its regulatory policy over the past few months to expedite the review of medical devices and therapies that use artificial intelligence. view the article